TWD 28.55
(-9.94%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -156.32 Million TWD | 15.25% |
2022 | -184.45 Million TWD | -33.19% |
2021 | -138.48 Million TWD | 4.88% |
2020 | -145.59 Million TWD | 10.63% |
2019 | -162.9 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -10.96 Million TWD | 66.48% |
2024 Q2 | -34.88 Million TWD | -218.22% |
2023 Q4 | -32.7 Million TWD | 22.8% |
2023 FY | -156.32 Million TWD | 15.25% |
2023 Q3 | -42.36 Million TWD | -41.11% |
2023 Q2 | -30.02 Million TWD | 41.39% |
2023 Q1 | -51.22 Million TWD | 3.91% |
2022 FY | -184.45 Million TWD | -33.19% |
2022 Q4 | -53.31 Million TWD | 0.0% |
2021 FY | -138.48 Million TWD | 4.88% |
2020 FY | -145.59 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | -201.891% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 162.278% |
Level Biotechnology Inc. | 62.9 Million TWD | 348.51% |
Sagittarius Life Science Corp | -55.03 Million TWD | -184.026% |
NeoCore Technology Co., Ltd. | -64.64 Million TWD | -141.821% |
TaiMed Biologics Inc. | -194.81 Million TWD | 19.755% |
GlycoNex Incorporation | -178.36 Million TWD | 12.355% |
VBI | -6.6 Million TWD | -2268.202% |
GeneReach Biotechnology Corp. | -166.27 Million TWD | 5.981% |
Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -1363.443% |
SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -309.528% |
Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 6.986% |
Visgeneer Inc. | -19.58 Million TWD | -698.024% |
Mycenax Biotech Inc. | -682.84 Million TWD | 77.107% |
Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 124.984% |
G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 315.919% |
Neith Corporation | -40.03 Million TWD | -290.49% |
Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 86.522% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -2485.166% |
Enimmune corporation | -223.74 Million TWD | 30.132% |
TaiRx, Inc. | -212.29 Million TWD | 26.363% |
CHO Pharma, Inc. | -306.08 Million TWD | 48.928% |
EirGenix Inc. | -915.2 Million TWD | 82.919% |
BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 414.265% |
Sunny Pharmtech Inc. | -63.32 Million TWD | -146.881% |
Lin BioScience, Inc. | -687.19 Million TWD | 77.252% |
Feng Chi Biotech Corp. | 22.79 Million TWD | 785.877% |
Bio Preventive Medicine Corp. | -73.28 Million TWD | -113.311% |
Lukas Biomedical Inc. | -47.35 Million TWD | -230.127% |
RBC Bioscience Corporation | 6.43 Million TWD | 2531.182% |
BiOptic Inc. | 37.74 Million TWD | 514.139% |
BRIM Biotechnology, Inc. | -688.02 Million TWD | 77.279% |
Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -320.624% |
Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | -154.022% |
Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 156.881% |
Advagene Biopharma Co., Ltd. | -92.11 Million TWD | -69.716% |
NaviFUS Corp. | -65.72 Million TWD | -137.833% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | -77.463% |
Sinew Pharma Inc. | -170.92 Million TWD | 8.54% |
Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | -129.353% |
Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 219.639% |
Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 34.329% |
AP Biosciences Inc | -339.29 Million TWD | 53.927% |
Medigen Biotechnology Corp. | -561.29 Million TWD | 72.149% |
3D Global Biotech Inc. | -57.95 Million TWD | -169.754% |
Pharmosa Biopharm Inc. | 8.45 Million TWD | 1948.687% |
Intech Biopharm Corporation | -337.98 Million TWD | 53.748% |
Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 88.093% |
Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -202.879% |
TWi Biotechnology, Inc. | -170.68 Million TWD | 8.412% |
Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 128.981% |
TCI GENE Inc. | 11.67 Million TWD | 1439.202% |
MegaPro Biomedical Co., Ltd | -127.54 Million TWD | -22.562% |
Senhwa Biosciences, Inc. | -296.3 Million TWD | 47.242% |
Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 28.13% |
NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 1644.713% |
PharmaEngine, Inc. | 274.65 Million TWD | 156.918% |
Savior Lifetec Corporation | 30.03 Million TWD | 620.563% |
TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 214.33% |
OBI Pharma, Inc. | -1.04 Billion TWD | 85.062% |
Meribank Biotech Co., Ltd | -125.34 Million TWD | -24.715% |
Acepodia, Inc. | -817.31 Million TWD | 80.873% |
Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 67.996% |